- Author:
Ya-Nan QIU
1
;
Feng-Hua FU
1
;
Ya-Nan QIU
2
;
Yi SUN
2
;
Rui-Bin SU
2
Author Information
- Publication Type:Journal Article
- Keywords: addiction; analgesia; anesthesia; anti-addiction; anti-depression; ketamine; opioid receptor
- From: Chinese Pharmacological Bulletin 2023;39(6):1019-1022
- CountryChina
- Language:Chinese
- Abstract: Ketamine has been used clinically as an analgesic and anesthetic since 1970. Recently, it has been concerned due to its rapid and effective antidepressant effect. However, the psychiatric adverse reactions caused by ketamine such as addiction and hallucination limit its clinical application, yet the mechanism of the adverse reactions is still unclear. At present, it is generally believed that the pharmacological effects of ketamine are mainly mediated by N-methyl-D-aspartate acid (NMDA) receptors, but increasing numbers of research evidences suggest that the opioid receptor also play an important role in the pharmacological effects of ketamine. This review, based on the relevant literature published publicly in the past 20 years, summarizes the mechanisms of opioid receptors in the pharmacological effects of ketamine, such as anesthesia, analgesia, anti-depressant, anti-addiction and addiction, providing reference for revealing the mechanism of ketamine, and making beneficial exploration for solving the clinical side effects of ketamine.